Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.6 INR | -0.05% | -4.60% | +8.95% |
30/05 | Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets | MT |
13/05 | Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 | CI |
End-of-day quotes
Sector Other Real Estate Development & Operations
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
26.36B | ||||||
25.9B | ||||||
25.67B | ||||||
24.19B | ||||||
21.26B |